Journal of Molecular Endocrinology

References

1. ↵
   1. Adashi EY,
   2. Jones PB &
   3. Hsueh AJ

   1983 Direct antigonadal activity of cannabinoids: suppression of rat granulosa cell functions. American Journal of Physiology 244 E177–E185.
2. ↵
   1. Ahren B

   2009 Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes. Nature Reviews. Drug Discovery 8 369–385. (doi:10.1038/nrd2782).
3. ↵
   1. Alessandro R &
   2. Kohn EC

   2002 Signal transduction targets in invasion. Clinical & Experimental Metastasis 19 265–273. (doi:10.1023/A:1015547804511).
4. ↵
   1. Anand-Apte B &
   2. Zetter B

   1997 Signalling mechanisms in growth factor stimulated cell motility. Stem Cells 15 259–267. (doi:10.1002/stem.150259).
5. ↵
   1. Battista N,
   2. Gasperi V,
   3. Fezza F &
   4. Maccarrone M

   2005 The anandamide membrane transporter and the therapeutic implications of its inhibition. Therapy 2 141–150. (doi:10.2217/14750708.2.1.141).
6. ↵
   1. Battista N,
   2. Pasquariello N,
   3. Di Tommaso M &
   4. Maccarrone M

   2008 Interplay between endocannabinoids, steroids and cytokines in the control of human reproduction. Journal of Neuroendocrinology 20 82–89. (doi:10.1111/j.1365-2826.2008.01684.x).
7. ↵
   1. Bellocchio L,
   2. Vicennati V,
   3. Cervino C,
   4. Pasquali R &
   5. Pagotto U

   2007 The endocannabinoid system in the regulation of cardiometabolic risk factors. American Journal of Cardiology 100 7P–17P. (doi:10.1016/j.amjcard.2007.10.009).
8. ↵
   1. Bermudez-Siva FJ,
   2. Serrano A,
   3. Diaz-Molina FJ,
   4. Vera IS,
   5. Juan-Pico P,
   6. Nadal A,
   7. Fuentes E &
   8. de Fonseca FR

   2006 Activation of cannabinoid CB1 receptors induces glucose intolerance in rats. European Journal of Pharmacology 531 282–284. (doi:10.1016/j.ejphar.2005.12.016).
9. ↵
   1. Das SK,
   2. Paria BC,
   3. Chakraborty I &
   4. Dey SK

   1995 Cannabinoid ligand-receptor signaling in the mouse uterus. PNAS 92 4332–4336. (doi:10.1073/pnas.92.10.4332).
10. ↵
    1. Day TA,
    2. Rakhshan FR,
    3. Deutsch DG &
    4. Baker EL

    2001 Role of fatty acid amide hydrolase in the transport of endogenous cannabinoid anandamide. Molecular Pharmacology 59 1369–1375.
11. ↵
    1. Devane WA,
    2. Dysarz FA III.,
    3. Johnson MR,
    4. Melvin LS &
    5. Howlett AC

    1988 Determination and characterization of a cannabinoid receptor in the rat brain. Molecular Pharmacology 34 605–613.
12. ↵
    1. Diaz-Laviada J &
    2. Ruiz-Llorente I

    2005 Signal transduction activated by cannabinoid receptors. Mini Reviews in Medicinal Chemistry 5 619–630. (doi:10.2174/1389557054368808).
13. ↵
    1. Ellert-Miklaszewska A,
    2. Ciechomska I &
    3. Kaminska B

    2013 Cannabinoid signaling in glioma cells. Advances in Experimental Medicine and Biology 986 209–220.
14. ↵
    El-Talatini MR, Elson JC, Taylor AH & Konje JC 2007 The endocannabinoid, anandamide, is involved in human folliculogenesis and oocyte maturation during IVF treatment. 2nd SGI International Summit in Reproductive medicine-From embryo and endometrium to implantation, Valencia, Spain, P2. 59p
15. ↵
    El-Talatini MR, Taylor AH & Konje JC 2008 Longitudinal study showing the relationship between anandamide and sex steroids and gonadotrophin hormones in women. In: 18th Annual Symposium of the International Cannabinoid Research Society, Aviemore, Scotland, UK. 45p
16. ↵
    1. El-Talatini MR,
    2. Taylor AH,
    3. Elson JC,
    4. Brown L,
    5. Davidson AC &
    6. Konje JC

    2009 Localisation and function of the endocannabinoid system in the human ovary. PLoS ONE 4 e4579. (doi:10.1371/journal.pone.0004579).
17. ↵
    1. Friedl P &
    2. Wolf K

    2003 Tumour-cell invasion and migration: diversity and escape mechanisms. Nature Reviews. Cancer 3 362–374. (doi:10.1038/nrc1075).
18. ↵
    1. Gambineri A,
    2. Pelusi C,
    3. Manicardi E,
    4. Vicennati V,
    5. Cacciari M,
    6. Morselli Labate AM,
    7. Pagotto U &
    8. Pasquali R

    2004 Glucose intolerance in a large cohort of Mediterranean women with polycystic ovary syndrome. Phenotype and associated factors. Diabetes 53 2353–2358. (doi:10.2337/diabetes.53.9.2353).
19. ↵
    1. Gasperi V,
    2. Fezza F,
    3. Pasquariello N,
    4. Bari M,
    5. Oddi S,
    6. Finazzi-Agrò A &
    7. Maccarrone M

    2007 Endocannabinoids in adipocytes during differentiation and their role in glucose uptake. Cellular and Molecular Life Sciences 64 219–229. (doi:10.1007/s00018-006-6445-4).
20. ↵
    1. Gentilini D,
    2. Besana A,
    3. Vigano P,
    4. Dalino P,
    5. Vignali M,
    6. Melandri M,
    7. Busacca M &
    8. Di Blasio AM

    2010 The Endocannabinoid system regulates migration of endometrial stromal cells via cannabinoid receptor 1 through the activation of PI3K and ERK1/2 pathways. Fertility and Sterility 93 2588–2593. (doi:10.1016/j.fertnstert.2010.02.006).
21. ↵
    1. Guzeloglu-Kayisli O,
    2. Kayisli UA,
    3. Luleci G &
    4. Arici A

    2004 In vivo and in vitro regulation of Akt activation in human endometrial cells is estrogen dependent. Biology of Reproduction 7 714–721. (doi:10.1095/biolreprod.104.027235).
22. ↵
    1. Habayeb OM,
    2. Bell SC &
    3. Konje JC

    2002 Endogenous cannabinoids: metabolism and their role in reproduction. Life Sciences 70 1963–1977. (doi:10.1016/S0024-3205(01)01539-9).
23. ↵
    1. Heilman RD,
    2. Reo RR &
    3. Hahn DW

    1976 Changes in the sensitivity of adrenergic receptors in the oviduct during early gestation in the rabbit. Fertility and Sterility 27 426–430.
24. ↵
    1. Hermann A,
    2. Kaczocha M &
    3. Deutsch DG

    2006 2-Arachidonoylglycerol (2-AG) membrane transport: history and outlook. AAPS Journal 8 E409–E412.
25. ↵
    1. Hillard CJ &
    2. Jarrajan A

    2003 Cellular accumulation of anandamide: consensus and controversy. British Journal of Pharmacology 140 802–808. (doi:10.1038/sj.bjp.0705468).
26. ↵
    1. Ho WS,
    2. Barrett DA &
    3. Randall MD

    2008 “Entourage” effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur though TRPV1 receptors. British Journal of Pharmacology 155 837–846. (doi:10.1038/bjp.2008.324).
27. ↵
    1. Hotulainen P &
    2. Lappalainen P

    2006 Stress fibers are generated by two distinct actin assembly mechanisms in motile cells. Journal of Cell Biology 173 383–394. (doi:10.1083/jcb.200511093).
28. ↵
    1. Howe GR &
    2. Black DL

    1973 Autonomic nervous system and oviduct function in the rabbit. I. Hormones and contraction. Journal of Reproduction and Fertility 33 425–430.
29. ↵
    1. Howlett AC,
    2. Barth F,
    3. Bonner TI,
    4. Cabral G,
    5. Casellas P,
    6. Devane WA,
    7. Felder CC,
    8. Herkenham M,
    9. Mackie K,
    10. Martin BR
    11. et al.

    2002 International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacological Reviews 54 161–202. (doi:10.1124/pr.54.2.161).
30. ↵
    1. Huang SM,
    2. Bisogno T,
    3. Trevisani M,
    4. Al-Hayani A,
    5. De Petrocellis L,
    6. Fezza F,
    7. Tognetto M,
    8. Petros TJ,
    9. Krey JF,
    10. Chu CJ
    11. et al.

    2002 An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. PNAS 98 8400–8405. (doi:10.1073/pnas.122196999).
31. ↵
    1. Karasu T,
    2. Marczylo TH,
    3. Maccarone M &
    4. Konje JC

    2011 The role of sex steroid hormones, cytokines and the endocannabinoid system in female fertility. Human Reproduction Update 17 347–361. (doi:10.1093/humupd/dmq058).
32. ↵
    1. Katona I &
    2. Freund TF

    2008 Endocannabinoid signalling as a synaptic circuit breaker in neurological disease. Nature Medicine 14 923–930. (doi:10.1038/nm.f.1869).
33. ↵
    1. Kessler CA,
    2. Moghadam KK,
    3. Schroeder JK,
    4. Buckley AR,
    5. Brar AK &
    6. Handwerger S

    2005 Cannabinoid receptor I activation markedly inhibits human decidualization. Molecular and Cellular Endocrinology 229 65–74. (doi:10.1016/j.mce.2004.09.007).
34. ↵
    1. Klein TW

    2005 Cannabinoid-based drugs as anti-inflammatory therapeutics. Nature Reviews. Immunology 5 400–411. (doi:10.1038/nri1602).
35. ↵
    1. Klonoff-Cohen HS,
    2. Natarajan L &
    3. Chen RV

    2006 A prospective study of the effects of female and male marijuana use on in vitro fertilization (IVF) and gamete intrafallopian transfer (GIFT) outcomes. American Journal of Obstetrics and Gynecology 194 369–376. (doi:10.1016/j.ajog.2005.08.020).
36. ↵
    1. Lauckner JE,
    2. Jensen JB,
    3. Chen HY,
    4. Lu HC,
    5. Hille B &
    6. Mackie K

    2008 GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. PNAS 105 2699–2704. (doi:10.1073/pnas.0711278105).
37. ↵
    1. Leconte M,
    2. Nicco C,
    3. Ngo C,
    4. Arkwright S,
    5. Chereau C,
    6. Guibourdenche J,
    7. Weill B,
    8. Chapron C,
    9. Dousset B &
    10. Batteux F

    2010 Antiproliferative effects of cannabinoid agonists on deep infiltrating endometriosis. American Journal of Pathology 177 2963–2970. (doi:10.2353/ajpath.2010.100375).
38. ↵
    1. Ligresti A,
    2. Cascio MG &
    3. Di Marzo V

    2005 Endocannabinoid metabolic pathways and enzymes. Current Drug Targets. CNS and Neurological Disorders 4 615–623. (doi:10.2174/156800705774933104).
39. ↵
    1. Liu J,
    2. Wang L,
    3. Harvey-White J,
    4. Osei-Hyiaman D,
    5. Razdan R,
    6. Gong Q,
    7. Chan AC,
    8. Zhou Z,
    9. Huang BX,
    10. Kim HY
    11. et al.

    2006 A biosynthetic pathway for anandamide. PNAS 103 13345–13350. (doi:10.1073/pnas.0601832103).
40. ↵
    1. Maccarone M

    2009 Endocannabinoids: friends and foes of reproduction. Progress in Lipid Research 48 344–354. (doi:10.1016/j.plipres.2009.07.001).
41. ↵
    1. Maccarrone M,
    2. Bisogno T,
    3. Valensise H,
    4. Lazzarin N,
    5. Fezza F,
    6. Manna C,
    7. Di Marzo V &
    8. Finazzi-Agrò A

    2002 Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve ongoing pregnancy after IVF and embryo transfer. Molecular Human Reproduction 8 188–195. (doi:10.1093/molehr/8.2.188).
42. ↵
    1. Matsusa LA,
    2. Lolait SJ,
    3. Brownstein MJ,
    4. Young AC &
    5. Bonner TI

    1990 Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346 561–564. (doi:10.1038/346561a0).
43. ↵
    1. McFarland MJ,
    2. Porter AC,
    3. Rakhshan FR,
    4. Ravat DS,
    5. Gibbs RA &
    6. Baker EL

    2004 A role for caveolae/lipid rafts in the uptake and recycling of the endogenous cannabinoid anandamide. Journal of Biological Chemistry 279 41991–41997. (doi:10.1074/jbc.M407250200).
44. ↵
    1. McHugh DJ,
    2. Page Dunn E &
    3. Bradshaw HB

    2011 Delta(9)-THC and N-arachidonyl glycine are full agonists at GPR18 and cause migration in the human endometrial cell line, HEC-1B. British Journal of Pharmacology 8 2411–2413.
45. ↵
    1. McKinney MK &
    2. Cravatt BF

    2005 Structure and function of fatty acid amide hydrolase. Annual Review of Biochemistry 74 411–432. (doi:10.1146/annurev.biochem.74.082803.133450).
46. ↵
    1. Mitchell MD,
    2. Sato TA,
    3. Wang A,
    4. Keelan JA,
    5. Ponnampalam AP &
    6. Glass M

    2008 Cannabinoids stimulate prostaglandin production by human gestational tissue through a tissue- and CBr1-receptor-specific mechanism. American Journal of Physiology. Endocrinology and Metabolism 294 352–356. (doi:10.1152/ajpendo.00495.2007).
47. ↵
    1. Mueller BA,
    2. Daling JR,
    3. Weiss NS &
    4. Moore DE

    1990 Recreational drug use and the risk of primary infertility. Epidemiology 1 195–200. (doi:10.1097/00001648-199005000-00003).
48. ↵
    1. Munro S,
    2. Thomas KL &
    3. Abu-Shaar M

    1993 Molecular characterization of a peripheral receptor for cannabinoids. Nature 365 61–65. (doi:10.1038/365061a0).
49. ↵
    1. Murphy LL,
    2. Steger RW,
    3. Smith MS &
    4. Bartke A

    1990 Effects of Δ⁹-tetrahydro-cannabinol, cannabinol and cannabidiol, alone and in combinations,. on luteinizing hormone and prolactin release and on hypothalamic neurotransmitters in the male rat. Neuroendocrinology 52 316–321. (doi:10.1159/000125604).
50. ↵
    1. Nir I,
    2. Ayalon D,
    3. Tsafriri A,
    4. Cordova T &
    5. Lindner HR

    1973 Suppression of the cyclic surge of luteinizing hormone secretion and ovulation in the rat by D1-tetrahydrocannabinol. Nature 243 470–471. (doi:10.1038/243470a0).
51. ↵
    1. Nogueiras R,
    2. Diaz-Arteaga A,
    3. Lockie SH,
    4. Velásquez DA,
    5. Tschop J,
    6. López M,
    7. Cadwell CC,
    8. Diéguez C &
    9. Tschöp MH

    2009 The endocannabinoid system: role in glucose and energy metabolism. Pharmacological Research 60 93–98. (doi:10.1016/j.phrs.2009.04.004).
52. ↵
    1. Okamoto Y,
    2. Morishita J,
    3. Tsuboi K,
    4. Tonai T &
    5. Ueda N

    2004 Molecular characterization od a phospholipase D generating anandamide and its congeners. Journal of Biological Chemistry 279 5298–5305. (doi:10.1074/jbc.M306642200).
53. ↵
    1. O'Sullivan SE

    2007 Cannabinoids go nuclear: evidence for activation of peroxisome proliferators-activated receptors. British Journal of Pharmacology 152 576–578. (doi:10.1038/sj.bjp.0707423).
54. ↵
    1. Pacher P,
    2. Mukhopadhyay P,
    3. Mohhanraj R,
    4. Godlewsi G,
    5. Batkai S &
    6. Kunos G

    2008 Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitation. Hypertension 52 601–607. (doi:10.1161/HYPERTENSIONAHA.105.063651).
55. ↵
    1. Pagotto U,
    2. Marsicano G,
    3. Cota D,
    4. Lutz B &
    5. Pasquali R

    2006 The emerging role of endocannabinoid system in endocrine regulation and energy balance. Endocrine Reviews 27 73–100. (doi:10.1210/er.2005-0009).
56. ↵
    1. Paria BC,
    2. Zhao X,
    3. Wang J,
    4. Das SK &
    5. Dey SK

    1999 Fatty-acid amide hydrolase is expressed in the mouse uterus and embryo during the periimplantation period. Biology of Reproduction 60 1151–1157. (doi:10.1095/biolreprod60.5.1151).
57. ↵
    1. Paria BC,
    2. Song H,
    3. Wang X,
    4. Schmid PC,
    5. Krebsbach RJ,
    6. Schmid HH,
    7. Bonner TI,
    8. Zimmer A &
    9. Dey SK

    2001 Dysregulated cannabinoid signaling disrupts uterine receptivity for embryo implantation. Journal of Biological Chemistry 276 20523–20528. (doi:10.1074/jbc.M100679200).
58. ↵
    1. Pasquali R,
    2. Gambineri A &
    3. Pagotto U

    2006 The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG: an International Journal of Obstetrics and Gynaecology 113 1148–1159. (doi:10.1111/j.1471-0528.2006.00990.x).
59. ↵
    1. Pasquali R,
    2. Patton L &
    3. Gambineri A

    2007 Obesity and infertility. Current Opinion in Endocrinology, Diabetes, and Obesity 14 482–487. (doi:10.1097/MED.0b013e3282f1d6cb).
60. ↵
    1. Prescott SM &
    2. Majerus PW

    1983 Characterization of 1,2-diacylglycerol hydrolysis in human platelets. Demonstration of an arachidonoyl–monoacylglycerol intermediate. Journal of Biological Chemistry 258 764–769.
61. ↵
    1. Resuehr D,
    2. Glore DR,
    3. Taylor HS,
    4. Bruner-Tran KL &
    5. Osteen KG

    2012 Progesterone dependent regulation of endometrial cannabinoid receptor type 1 (CB1-R) expression is disrupted in women with endometriosis and in isolated stromal cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Fertility and Sterility 98 948.e1–956.e1. (doi:10.1016/j.fertnstert.2012.06.009).
62. ↵
    1. Ross RA

    2009 The enigmatic pharmacology of GPR55. Trends in Pharmacological Sciences 30 156–163. (doi:10.1016/j.tips.2008.12.004).
63. ↵
    1. Rouzer CA &
    2. Marnett LJ

    2008 Non-redundant functions of cyclooxygenases: oxygenation of endocannabinoids. Journal of Biological Chemistry 283 8065–8069. (doi:10.1074/jbc.R800005200).
64. ↵
    1. Salamonsen LA

    2003 Tissue injury and repair in the female human reproductive tract. Reproduction 125 301–311. (doi:10.1530/rep.0.1250301).
65. ↵
    1. Schmid PC,
    2. Paria BC,
    3. Krebsbach RJ,
    4. Schmid HH &
    5. Dey SK

    1997 Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation. PNAS 94 4188–4192. (doi:10.1073/pnas.94.8.4188).
66. ↵
    1. Schuel H,
    2. Burkman LJ,
    3. Lippes J,
    4. Crickard K,
    5. Forester E,
    6. Piomelli D &
    7. Giuffrida A

    2002 N-acylethanolamines in human reproductive fluids. Chemistry and Physics of Lipids 121 211–227. (doi:10.1016/S0009-3084(02)00158-5).
67. ↵
    1. Schwab A,
    2. Hanley P,
    3. Fabian A &
    4. Stock C

    2008 Potassium channels keep mobile cells on the go. Physiology 23 212–220. (doi:10.1152/physiol.00003.2008).
68. ↵
    1. Simon GM &
    2. Cravatt BF

    2006 Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha7beta hydrolase 4 in this pathway. Journal of Biological Chemistry 281 26465–26472. (doi:10.1074/jbc.M604660200).
69. ↵
    1. Snider NT,
    2. Sikora MJ,
    3. Sridar C,
    4. Feuerstein TJ,
    5. Rae JM &
    6. Hollenberg PF

    2008 The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6. Journal of Pharmacology and Experimental Therapeutics 327 538–545. (doi:10.1124/jpet.108.141796).
70. ↵
    1. Starowicz K,
    2. Nigam S &
    3. Di Marzo V

    2007 Biochemistry and pharmacology of endovanilloids. Pharmacology & Therapeutics 114 13–33. (doi:10.1016/j.pharmthera.2007.01.005).
71. ↵
    1. van der Stelt M,
    2. van Kuik JA,
    3. Bari M,
    4. van Zadelhoff G,
    5. Leeflang BR,
    6. Veldink GA,
    7. Finazzi-Agrò A,
    8. Vliegenthart JF &
    9. Maccarrone M

    2002 Oxygenated metabolites of anandamide and 2-arachidonoyldlycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter and fatty acid amide hydrolase. Journal of Medicinal Chemistry 45 3709–3720. (doi:10.1021/jm020818q).
72. ↵
    1. Taylor AH,
    2. Abbas MS,
    3. Habiba MA &
    4. Konje JC

    2010a Histomorphometric evaluation of cannabinoid receptor and anandamide modulating enzyme expression in the human endometrium through the menstrual cycle. Histochemistry and Cell Biology 133 557–565. (doi:10.1007/s00418-010-0695-9).
73. ↵
    1. Taylor AH,
    2. Amoako AA,
    3. Bambang K,
    4. Karasu T,
    5. Gebeh A,
    6. Lam PM,
    7. Marzcylo TH &
    8. Konje JC

    2010b Endocannabinoids and pregnancy. Clinica Chimica Acta 411 921–930. (doi:10.1016/j.cca.2010.03.012).
74. ↵
    1. Wang H,
    2. Guo Y,
    3. Wang D,
    4. Kingsley PJ,
    5. Marnett LJ,
    6. Das SK,
    7. DuBois RN &
    8. Dey SK

    2004 Aberrant cannabinoid signaling impairs oviductal transport of embryos. Nature Medicine 10 1074–1080. (doi:10.1038/nm1104).
75. ↵
    1. Wang H,
    2. Dey SK &
    3. Maccarrone M

    2006 Jekyll and Hyde: two faces of cannabinoid signalling in male and female fertility. Endocrine Reviews 27 427–428. (doi:10.1210/er.2006-0006).
76. ↵
    1. Wilkes S &
    2. Murdoch A

    2009 Obesity and female fertility: a primary care perspective. Journal of Family Planning and Reproductive Health Care 35 181–185. (doi:10.1783/147118909788707995).
77. ↵
    1. Zain MM &
    2. Norman RJ

    2008 Impact of obesity on female fertility and fertility treatment. Women's Health 4 183–194. (doi:10.2217/17455057.4.2.183).
78. ↵
    1. Zygmunt PM,
    2. Hogestatt ED,
    3. Julius D &
    4. Di Marzo V

    2000 Anandamide: the other side of the coin. Trends in Pharmacological Sciences 21 43–44. (doi:10.1016/S0165-6147(99)01430-3).